Knowing COVID-19 Kappa Variant

Table of contents:

Knowing COVID-19 Kappa Variant
Knowing COVID-19 Kappa Variant

Since its appearance, the Corona virus that causes COVID-19 has continued to mutate and produce new variants. One of the variants that recently appeared is the COVID-19 Kappa variant. Cases of this variant of COVID-19 are known to have been detected in Indonesia

COVID-19 Kappa variant or also known as variant code B.1.617.1 is one of the mutations of the Corona virus originating from India. This variant is known to have spread in various countries, from England, Germany, the United States, and even Indonesia.

Getting to know the Kappa Variant COVID-19 - Alodokter

The symptoms of the Kappa variant of COVID-19 are not much different from the symptoms of COVID-19 in general, namely fever, cough, headache, muscle aches, shortness of breath, and anosmia or loss of the ability to smell.

Facts About COVID-19 Kappa Variant

Just like the Delta variant of COVID-19, the first case of Kappa variant COVID-19 was also found in India in December 2020. However, the World He alth Organization (WHO) classifies these two COVID-19 variants into different groups. different.

COVID-19 Delta variant or B.1.617.2 has been categorized as one of the variants of concern (variants of concern) along with Alpha, Beta, and Gamma variants.

The classification of the Delta variant as a variant of concern is determined based on the amount of data that proves that this variant is more contagious and has the risk of causing complications compared to other COVID-19 variants.

Meanwhile, COVID-19 Kappa variant or B.1.617.1 is still classified as a variant of interest (variants of interest) along with COVID-19 Lambda, Eta, and Iota variants.

This is because there is no data or research that can confirm the level of transmission, severity, or types of symptoms caused by the Kappa variant COVID-19.

However, this does not mean that the COVID-19 Kappa variant will continue to be categorized as a variant of interest. The Kappa variant of COVID-19 may be classified as a variant of concern in the future if it proves to be more dangerous than other COVID-19 variants.

Ability of Vaccines against COVID-19 Kappa Variant

The various types of COVID-19 vaccines currently circulating are known to be effective and capable of providing protection against various variants of the Corona virus, including the Kappa variant.

Several studies have also investigated the effectiveness of COVID-19 vaccines, such as AstraZeneca, which is based on a genetically modified virus, and Pfizer and Moderna, which are mRNA vaccines, against the Kappa variant of COVID-19.

The results of this study prove that the COVID-19 vaccine is able to form an immune response that is strong enough to fight against the Kappa variant of COVID-19 and other variants of the Corona virus.

However, to optimize the antibodies formed by the body to fight Corona virus infection, you still need to get the full dose of COVID-19 vaccine, which is two doses.

Not only does it give the body maximum protection from the Corona virus, receiving a complete dose of vaccine will also accelerate the formation of herd immunity to end the COVID-19 pandemic.

In addition to receiving the vaccine, you also need to be disciplined in implementing he alth protocols so that the risk of contracting various variants of COVID-19, including the Kappa variant that has been found in Indonesia, can be minimized.

If you still have questions regarding the Kappa variant COVID-19 or information about the COVID-19 vaccine, don't hesitate to consult a doctor. You can also call the COVID-19 hotline at 119 or use the ALODOKTER app to chat with doctors.

Popular topic